End-stage Kidney Disease Clinical Trials in London, Ontario
3 recruitingLondon, Ontario, Canada
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
End-stage Kidney DiseaseAtherosclerotic Cardiovascular DiseaseAtherosclerotic Cardiovascular Disease in Patients With ESKD
CSL Behring2,310 enrolled542 locationsNCT05485961
Recruiting
Not Applicable
DIALysis With EXpanded Solute Removal
Kidney DiseaseChronic Kidney Disease Requiring HemodialysisHemodialysis+5 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's4,800 enrolled1 locationNCT06660277
Recruiting
Phase 4
Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
End-stage Kidney Disease
University of Sydney50,000 enrolled264 locationsNCT02823821